pancreatic cancer

5 Cancer Vaccines to Watch in 2024
5 Cancer Vaccines to Watch in 2024
BioSpace
Merck
Moderna Therapeutics
melanoma
BioNTech
pancreatic cancer
OSE Immunotherapeutics
Transgene
non-small cell lung cancer
Nykode Therapeutics
cervical cancer
Flag link:
BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials
BPGbio to accelerate pancreatic cancer drug after ‘promising’ initial trials
Biopharma Reporter
BPGbio
artificial intelligence
pancreatic cancer
BPM 31510
clinical trials
Flag link:
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
BioSpace
Cardiff Oncology
pancreatic cancer
Onvansertib
clinical trials
Flag link:
Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer
Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer
BioSpace
Novartis
Xoma
NIS793
pancreatic cancer
Flag link:
Novartis axes secretive obesity program after high-risk, high-reward bet fails
Novartis axes secretive obesity program after high-risk, high-reward bet fails
Fierce Biotech
Novartis
obesity
pancreatic cancer
Flag link:
Galera earns key FDA designation for pancreatic cancer drug
Galera earns key FDA designation for pancreatic cancer drug
Clinical Trials Arena
Galera Therapeutics
pancreatic cancer
FDA
rucosopasem
orphan drugs
Flag link:
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
BioNTech, Roche's experimental pancreatic cancer treatment wins Nature plaudit
Yahoo/Reuters
BioNTech
Roche
Genentech
pancreatic cancer
MRNA
Nature
vaccines
Flag link:
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
Fierce Biotech
AstraZeneca
Claudin18.2
KYM Biosciences
antibody-drug conjugate
pancreatic cancer
Flag link:
Ipsen reports positive data from pancreatic ductal adenocarcinoma trial
Ipsen reports positive data from pancreatic ductal adenocarcinoma trial
Clinical Trials Arena
Ipsen
Onivyde
metastatic pancreatic cancer
pancreatic cancer
clinical trials
Flag link:
MD Anderson Delivers a Triple Punch to Pancreatic Cancer
MD Anderson Delivers a Triple Punch to Pancreatic Cancer
BioSpace
MD Anderson
pancreatic cancer
Flag link:
Oncolytics Presents Promising Pancreatic Cancer Data at SITC
Oncolytics Presents Promising Pancreatic Cancer Data at SITC
BioSpace
Oncolytics
pancreatic cancer
SITC
clinical trials
pelareorep
Flag link:
Report: Cancer deaths are down but pancreatic cancer is growing, racial disparities persist
Report: Cancer deaths are down but pancreatic cancer is growing, racial disparities persist
MedCity News
cancer
pancreatic cancer
Flag link:
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Endpoints
Elevation Oncology
gastric cancer
pancreatic cancer
antibody-drug conjugate
Flag link:
ASCO: BioNTech's Roche-partnered cancer vaccine combo hints at survival benefit in prostate cancer
ASCO: BioNTech's Roche-partnered cancer vaccine combo hints at survival benefit in prostate cancer
Fierce Biotech
ASCO 2022
BioNTech
Roche
vaccines
cancer vaccines
pancreatic cancer
Flag link:
US Bridging Study Not Enough as FDA Denies Hutchmed's Pancreatic Cancer Drug
US Bridging Study Not Enough as FDA Denies Hutchmed's Pancreatic Cancer Drug
BioSpace
FDA
Hutchmed
pancreatic cancer
surufatinib
Flag link:
Four Cancer Clinical Trials Advance with Blessing of FDA
Four Cancer Clinical Trials Advance with Blessing of FDA
BioSpace
cancer
oncology
FDA
clinical trials
Sonnet BioTherapeutics
SON-1010
solid tumors
Adagene
AD126
AIM ImmunoTech
Ampligen
pancreatic cancer
Wugen
WU-CART-007
Flag link:
Rafael resets after phase 3 flop, parting ways with 5 execs and reinstating telecom tycoon as CEO
Rafael resets after phase 3 flop, parting ways with 5 execs and reinstating telecom tycoon as CEO
Fierce Biotech
Rafael Pharmaceuticals
devimistat
clinical trials
pancreatic cancer
AML
reorganization
Flag link:
SITC: Cellectis' off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice
SITC: Cellectis' off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice
Fierce Biotech
Cellectis
CAR-T
cancer
pancreatic cancer
mesothelioma
SITC
Flag link:
The quest for efficacy in pancreatic cancer
The quest for efficacy in pancreatic cancer
EP Vantage
pancreatic cancer
Novartis
FibroGen
Tyme Technologies
Erytech
Rafeal Pharmaceuticals
Flag link:
A transatlantic biotech flags a painful PhIII cancer flop, waving a white flag
A transatlantic biotech flags a painful PhIII cancer flop, waving a white flag
Endpoints
Erytech
clinical trials
eryapase
pancreatic cancer
Flag link:

Pages